CoChat

The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy

Bentahila, Rita, Giraud, Philippe, Decazes, Pierre, Kreps, Sarah, Nay, Paula, Chatain, Augustin, Fabiano, Emmanuelle, Durdux, Catherine · 2023 · Cancer Medicine
Cited by 20

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Sarcopenia appears to be a negative prognostic factor for poor survival outcomes and worse treatment tolerance in patients with head‐and‐neck squamous cell carcinoma (HNSCC). We evaluated sarcopenia's impact on overall survival (OS), disease‐free survival (DFS) and chemo‐radiation tolerance in patients with head‐and‐neck cancer (HNC) treated with chemoradiotherapy (CRT) from a monocentric observational study. Methods: We identified patients with HNC treated by CRT between 2009 and 2018 with pretreatment imaging using positron emission tomography–computed tomography scans (PET/CT). Sarcopenia was measured using the pretreatment PET/CT at the L3 vertebral body using previously published methods. Clinical variables were retrospectively retrieved. Results: Of 216 patients identified, 54 patients (25.47%) met the criteria for sarcopenia. These patients had a lower mean body mass index before treatment (21.92 vs. 25.65 cm/m 2, p < 0.001) and were more likely to have a history of smoking (88.89% vs. 71.52%, p = 0.01), alcohol use (55.56% vs. 38.61%, p = 0.03) and positive human papilloma virus status (67.74% vs. 41.75%, p = 0.011). At 3 years of follow‐up, OS and DFS were 75% and 70% versus 82% and 85% for sarcopenic and non‐sarcopenic patients, respectively (p = 0.1 and p = 0.00015). On multivariate analysis, sarcopenia appeared as a pejorative factor on DFS (hazard ratio 2.174, p = 0.0001) in the overall cohort. Sarcopenic patients did not require more chemotherapy and radiation‐treatment interruptions and did not suffer from more chemo‐induced and radiation‐induced grade 3–4 toxicities than their non‐sarcopenic counterparts. Conclusion: Sarcopenia in HNSCC patients is an independent adverse prognostic factor for DFS after definitive chemoradiotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cam4.5278

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 40

  1. 10.1016/j.ejca.2015.12.030 · DOI · Paper page
  2. 10.1016/j.semcdb.2015.09.001 · DOI · Paper page
  3. 10.1016/j.berh.2017.11.007 · DOI · Paper page
  4. 10.1158/1078-0432.CCR-08-2242 · DOI · Paper page
  5. 10.1038/sj.bjc.6605578 · DOI · Paper page
  6. 10.1177/0148607113502674 · DOI · Paper page
  7. 10.1001/jamaoncol.2015.6339 · DOI · Paper page
  8. 10.1016/j.oraloncology.2017.05.012 · DOI · Paper page
  9. 10.1159/000485515 · DOI
  10. 10.1177/0194599818793857 · DOI
  11. 10.3389/fonc.2018.00457 · DOI
  12. 10.1007/s00405-019-05361-4 · DOI
  13. 10.1016/j.ejca.2019.05.006 · DOI
  14. 10.1016/j.radonc.2019.04.023 · DOI
  15. 10.1016/j.clnu.2020.09.017 · DOI
  16. 10.1007/s00405-020-06273-4 · DOI
  17. 10.1016/j.radonc.2020.03.014 · DOI
  18. 10.1002/lary.29221 · DOI
  19. 10.1016/j.radonc.2013.11.010 · DOI · Paper page
  20. 10.1016/j.oraloncology.2017.06.003 · DOI
  21. 10.1016/j.ijrobp.2016.08.046 · DOI
  22. 10.1016/j.ijrobp.2013.12.027 · doi:10.1016/j.ijrobp.2013.12.027
  23. 10.1016/S0167-8140(97)00079-0 · DOI · Paper page
  24. 10.1200/JCO.2003.01.008 · DOI · Paper page
  25. 10.1200/JCO.2014.55.3925 · DOI · Paper page
  26. 10.1056/NEJMoa070956 · DOI · Paper page
  27. 10.1016/S1470-2045(10)70279-5 · DOI · Paper page
  28. 10.1245/s10434-010-0985-4 · DOI · Paper page
  29. Tonnelet D, 2018, Évaluation d'Anthropometer 3D, logiciel d'extraction automatique de multiples paramètres anthropométriques à partir des tomodensitométries des TEP/TDM, Médecine Nucléaire, 42, 142, 10.1016/j.mednuc.2018.03.027 · doi:10.1016/j.mednuc.2018.03.027
  30. 10.1007/s10278-019-00178-3 · DOI
  31. 10.1002/jpen.1721 · DOI
  32. 10.1017/BJN20061943 · DOI · Paper page
  33. 10.1097/MCO.0b013e32832a7902 · DOI · Paper page
  34. 10.3389/fonc.2019.01561 · DOI
  35. 10.1016/j.oraloncology.2016.09.006 · DOI · Paper page
  36. 10.3389/fonc.2022.812159 · DOI
  37. 10.1177/0194599814538605 · doi:10.1177/0194599814538605
  38. 10.1016/j.amjoto.2013.07.010 · doi:10.1016/j.amjoto.2013.07.010
  39. 10.1007/s00520-009-0717-0 · DOI · Paper page
  40. 10.1186/s12885-017-3388-0 · DOI

Metadata

Authors
Bentahila, R., Giraud, P., Decazes, P., Kreps, S., Nay, P., Chatain, A., Fabiano, E., & Durdux, C.
Venue
Cancer Medicine
Publisher
Wiley
Published
2022-10-20
Volume
12
Issue
4
Pages
4170-4183
ISSN
2045-7634
Cited by
20
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy. https://app.cochat.ai/papers/10.1002/cam4.5278
The paper
Bentahila, R., Giraud, P., Decazes, P., Kreps, S., Nay, P., Chatain, A., Fabiano, E., & Durdux, C. (2023). The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy. Cancer Medicine. https://doi.org/10.1002/cam4.5278

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.